Heart Failure with Recovered Ejection Fraction in Patients with Vinculin Loss-of-function Variants

J Cardiovasc Transl Res. 2023 Dec;16(6):1303-1309. doi: 10.1007/s12265-023-10421-6. Epub 2023 Aug 7.

Abstract

Predictors of myocardial recovery in heart failure (HF) are poorly understood. We explored if vinculin (VCL) variants are associated with myocardial recovery in dilated cardiomyopathy (DCM). Six infants with DCM with a VCL loss-of-function (LOF) variant were identified. Median age at diagnosis was 2 months, median LV ejection fraction was 24%, and median LV end-diastolic diameter z-score was 10.8. All patients received HF medications. Five patients (83%) showed normalization of LV function at a median age of 2.7 years. One patient progressed to end-stage HF requiring heart transplant. This case series identified a unique phenotype of HF with reduced ejection fraction at presentation that evolved to HF with recovered EF in over 80% of infant DCM cases with LOF VCL variants. These findings have prognostic implications for counseling and management of VCL-associated DCM and highlight a possible genetic basis for HF with recovered ejection fraction.

Keywords: Dilated cardiomyopathy; HFrEF; HFrecEF; Heart failure; Myocardial recovery; Vinculin.

MeSH terms

  • Child, Preschool
  • Heart Failure* / diagnosis
  • Heart Failure* / genetics
  • Humans
  • Infant
  • Prognosis
  • Stroke Volume
  • Ventricular Function, Left*
  • Vinculin / genetics

Substances

  • Vinculin